Executive Summary
altered peptide model definition designed versions of an original antigenic peptide by PP Yachi·2006·Cited by 202—Altered peptide ligands (APLs) arepeptide variants derived from the original antigenic peptide, with substitutions at particular residue(s). APLs can be
The altered peptide model is a fundamental concept in immunology that describes how modifications to peptides can significantly alter their interaction with the T-cell receptor (TCR) and influence immune responses. These modified peptides, known as altered peptide ligands (APLs), are essentially peptide variants derived from the original antigenic peptide, with specific changes, often at the amino acid level, that affect their presentation and recognition. Understanding the definition of the altered peptide model is crucial for comprehending various immunological phenomena, from autoimmune diseases to vaccine development and drug hypersensitivity.
At its core, the altered peptide concept revolves around the idea that even subtle changes in a peptide sequence can lead to a qualitatively different pattern of signal transduction events when recognized by a TCR. Altered peptide ligands are designed versions of an original antigenic peptide or intentionally modified versions of an original antigenic peptide. These modifications can occur naturally or be intentionally engineered. For instance, substitutions at particular residue(s) within a peptide can alter its binding affinity to Major Histocompatibility Complex (MHC) molecules or change the way it interacts with the TCR. This forms the basis of the altered peptide ligand (APL) model.
The significance of this model is highlighted in various research contexts. For example, the altered peptide repertoire hypothesis proposes that a drug can interact with HLA class I molecules in a specific and non-covalent fashion, effectively altering the repertoire of peptides presented to T cells. This interaction, where the drug binds non-covalently within the peptide-binding groove, thereby altering the chemistry of the antigen-binding cleft, is a key aspect of the altered peptide model in understanding drug hypersensitivity. Researchers have developed models to study these interactions, often involving multi-dimensional flow cytometry to evaluate the polyfunctionality of TCR gene expression.
Furthermore, altered peptide ligands can induce a qualitatively different pattern of signal transduction events than does any concentration of the native ligand. This means that while a native peptide might elicit a strong activating signal, an altered peptide might induce a weaker activation, anergy, or even antagonism. This differential signaling capacity is a cornerstone of the altered peptide model. Studies have shown that altered peptide ligands can induce delayed CD8-T cell receptor (TCR) signaling, demonstrating the nuanced impact of these modified peptides. The defined nature of these alterations allows for precise manipulation and study of TCR recognition.
The development of altered peptide ligands has profound implications for therapeutic interventions. For instance, modified synthetic peptides are being explored for their potential in vaccine design. By creating peptide variants that can elicit a more targeted or potent immune response, scientists aim to improve the efficacy of vaccines. Conversely, in the context of autoimmune diseases, altered peptide ligands might be used to induce tolerance or suppress aberrant immune responses. Research into therapeutic effect of an altered peptide ligand derived from heat-shock protein 60 by suppressing inflammatory cytokines secretion in animal models exemplifies this potential.
The precise nature of TCR recognition of these altered peptides is an active area of research. Structures of TCRs interacting with altered peptides reveal how mutations outside of anchor residues can still significantly impact how TCRs "see" the altered peptides surface. This understanding is crucial for designing immunotherapies that can precisely target specific T cell populations. The interaction between MHC and peptide is also complex, with studies revealing alternate interactions that define the binding of peptides to MHCII molecules.
In summary, the altered peptide model provides a framework for understanding how modifications to peptides, leading to the formation of altered peptide ligands, can profoundly influence immune responses. Whether these alterations are naturally occurring or intentionally modified, their impact on TCR signaling and immune cell behavior is significant. The ability to create and study these altered peptide variants, often referred to as APLs, opens avenues for novel therapeutic strategies and a deeper understanding of immune system dynamics. The concept of altered self-peptides is also relevant in the context of autoimmune diseases, where T cells may mistakenly target modified self-peptides.
Related Articles
Frequently Asked Questions
Here are the most common questions about altered peptide model definition.
Leave a Comment
Share your thoughts, feedback, or additional insights on this topic.
